Showing results (21-30 of 106) with videos related to
Sort By:
Pageof 11
Schizophrenia Research|July 13, 2012
Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patientsChristine Esslinger, Susanne Englisch, Dragos Inta, et al.Journal of Psychiatry & Neuroscience : JPN|October 1, 2014
Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophreniaFrederike Schirmbeck, Daniela Mier, Christine Esslinger, et al.European Archives of Psychiatry and Clinical Neuroscience|October 23, 2016
Aberrant activity and connectivity of the posterior superior temporal sulcus during social cognition in schizophreniaDaniela Mier, Sarah Eisenacher, Franziska Rausch, et al.Journal of Psychiatry & Neuroscience : JPN|January 27, 2015
Reduced activation in the ventral striatum during probabilistic decision-making in patients in an at-risk mental stateFranziska Rausch, Daniela Mier, Sarah Eifler, et al.Schizophrenia Research|May 17, 2014
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophreniaFranziska Rausch, Daniela Mier, Sarah Eifler, et al.Psychiatry Research|December 23, 2014
Metamemory in schizophrenia: retrospective confidence ratings interact with neurocognitive deficitsSarah Eifler, Franziska Rausch, Frederike Schirmbeck, et al.Early Intervention in Psychiatry|May 13, 2016
Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosisSarah Eisenacher, Franziska Rausch, Fabian Ainser, et al.Journal of Clinical Psychopharmacology|November 3, 2016
Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept StudySusanne Englisch, Hanna Sophie Jung, Antje Lewien, et al.Pharmacopsychiatry|May 8, 2018
Response to Agomelatine Treatment is Independent of Smoking Status and Dosage: Results From the AGOPSYCH StudySusanne Englisch, Hanna Sophie Jung, Antje Lewien, et al.Journal of Clinical Psychopharmacology|June 19, 2018
Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH StudySusanne Englisch, Hanna Sophie Jung, Sarah Eisenacher, et al.Pageof 11